Innovation‑led consulting across development and compliance
BACHwell Pharma Consulting is an innovation‑led consulting, research, development and manufacturing organization offering integrated scientific services from product development to commercial supply, and a fast‑growing HR recruitment agency. We help pharma and life sciences companies meet the highest standards of regulatory compliance, quality, and operational performance with hands‑on, pragmatic support.
Senior consultants with deep experience across development and compliance.
Successful filings across US, EU, Australia and other ROW markets.
From pre‑formulation to tech transfer, validation and launch.
Practical quality and regulatory strategies aligned to cGMP.
Customized end‑to‑end solutions that move beyond traditional outsourcing into true collaborations, covering R&D, manufacturing and scale‑up.
We recognize the importance of working diligently with appropriate timelines to achieve success for our clients while providing efficient services aligned to agreed schedules.
Mission: To support clients by developing complex ANDAs, 505(b)(2) products, novel drug delivery systems and novel strategies for bio/clinical waiver to provide affordable products for human suffering, and to be a premier recruiting firm connecting companies with exceptional talent.
Vision: To bring inspiration and innovation to drug discovery & development by offering value‑added services, solution‑driven initiatives and engineered processes. We aim to be a best‑in‑class research center of excellence, delivering transformative medicines and empowering innovative teams with cutting‑edge technologies.
From a small pharma consulting firm to Hyderabad's most rated pharma innovation company, our journey has been marked by continuous growth, innovation, and unwavering dedication to client success. With strong reviews and prestigious clients, we continue to push boundaries in excellence.
Director, R&D
Mr. Anil Chand epitomizes a visionary leader, steering the research and development division of our organization. With a formidable 24‑year trajectory, he brings deep expertise in the formulation of New Drug and Generic Products for USFDA, EU, TGA, MCC, and ROW markets.
His career flourished within distinguished enterprises such as Torrent, Sandoz, Emcure, and Lyrus LifeSciences. His proficiency spans Solid Oral, Liquid, and Injectable dosage forms, leading high‑performing scientific teams to deliver complex dosage forms.
He has submitted more than 150 products to authorities across the US, Europe, Canada, and Australia. His scientific acumen and commitment provide a unique vantage point across the product lifecycle—from due diligence and product selection to seamless launch operations.
Mr. Anil Chand holds a Master’s in Pharmaceutics from JSS College of Pharmacy, Ooty, India, and is acknowledged as principal inventor of several granted and pending patents.
